Further information regarding Orphan Drug Designation can be found at: Statements This news release includes forward-looking statements within the meaning of the U. All statements, other than statements of historical facts, included in this press release regarding the Company’s plans and objectives, expectations and assumptions of management are forward-looking statements.
The use of certain words, including the words “estimate,” “project,” “intend,” “expect,” “believe,” “anticipate,” “will, “plan,” “could,” “may” and similar expressions are intended to identify forward-looking statements.
While Chaldeans are believed to have immigrated to the United States as early as 1889, the first significant migration wave did not occur until around 1910, when Chaldeans began settling in metropolitan Detroit.
Further information regarding Biohaven can be found at: Fox Chase Chemical Diversity Center, Inc.
(FCCDC) Biohaven entered into a strategic alliance with FCCDC in October 2015 to develop Biohaven’s family of over 300 prodrugs of glutamate modulating agents as well as support other innovative initiatives.
The Company may not actually achieve the plans, intentions or expectations disclosed in the forward-looking statements and you should not place undue reliance on the Company’s forward-looking statements.
Various important factors could cause actual results or events to differ materially from those that may be expressed or implied by our forward-looking statements including receipt of regulatory approvals and market conditions.